Search results

Related work by the RKI: https://www.s4me.info/threads/long-term-health-consequences-among-individuals-with-sars-cov-2-infection-compared-to-individuals-without-infection-2023-heidemann-et-al.34900/#post-490426

Prevalence of Long COVID-associated symptoms in adults with and without SARS-CoV-2 infection in Germany: Results of the population-based study: Corona Monitoring Nationwide 2021/22 (RKI-SOEP-2) Abstract Background Controlled population-based studies on long-term health sequelae of SARS-CoV-2...

I suppose anybody improved that was part of the study, which is to be expected, and exercise didn't have beneficial effects on fatigue symptoms or quality of life in the study, but the only way to then still sell exercise as a treatment is to frame it as "Fatigue and quality of life improve over...

Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19 Abstract Previously, we and others have shown that SARS-CoV-2 spike-specific IgG antibodies play a major role in disease severity in COVID-19 by triggering macrophage hyperactivation...

When basically everything you do can change Gene expression so you use that as reasoning for anything being a treatment for ME/CFS. Next up: Farts change gene expression, so farting has to be a treatment for ME/CFS.

A Swiss team using a different method to Pretorius et al to assess "microclots" and platelet hyperactivation. This study is for acute Covid-19, but the authors are more than aware of Long Covid.

Digital holo-tomographic 3D maps of COVID-19 microclots in blood to assess disease severity Abstract The coronavirus disease 2019 (COVID-19) has impacted health globally. Cumulative evidence points to long-term effects of COVID-19 such as cardiovascular and cognitive disorders diagnosed in...

For what it's worth Karl Lauterbach seems to be the first and only health minister to ever take ME/CFS and Long Covid seriously and speak publicly about all problems. I hope some change is still possible under his reign, especially since what comes next doesn't look good at all, but knowing...

It doesn't seem so. The 15 Million are 5 Million per year for medical research. What Lauterbach wants, is 60 Million extra for healthcare research, for which 40 Million have already been allocated by him. However, as we know healthcare research is extremely useless if you don't do biomedical...

Comparison of semen parameters in the same patients before and after diagnosis of COVID-19 Abstract Clinical and histopathological evidence suggest that the male reproductive system may be negatively impacted in patients with coronavirus disease (COVID-19). The objective of this study is to...

Unfortunately, I couldn't find any information on funding. When I googled them I at least found out that they are currently recruiting for one position, probably not the worst of signs...

Merged thread Post-Acute Infection Syndromes Will Be the Focus of New YSM Center https://medicine.yale.edu/news-article/post-acute-infection-syndromes-will-be-the-focus-of-new-ysm-center/ Researchers will investigate Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and...

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency Abstract Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for prolonged SARS-CoV-2 infection, but the immune defects that predispose to persistent COVID-19 remain incompletely...

Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors Abstract Background The Long-COVID syndrome constitutes a plethora of persisting symptoms with neurological disorders being the most...

Yes, however the 40 million by Karl Lauterbach can only be used for health care research. So this budget is relatively useless if you don't spend money on biomedical research.

The first reports by politicians are that the allocated funding by the German Government is 10 Million for Long-Covid research and 5 Million for ME/CFS research for the year 2024. Sounds extremely dissapointing.

The donor that donated another 250K is Vitalik Buterin. He has also donated very large sums to PolyBio and the Patient-Led Research Collaborative. His key principles seem to be that everything is open source, is openly shared and a focus seems to be that progress should be quicker than going...

Polybio Fall 2023 Symposium "Join us online Friday Oct. 20 for updates on PolyBio supported projects & collaborations including those spearheaded by the #LongCovid Research Consortium. " Register on Zoom:https://us02web.zoom.us/webinar/register/WN__cnUbsaISb-D0AtXQ9yGbQ#/registration Speakers...

Merged thread Akiko Iwasaki speaks on BBC- Science in Action https://www.bbc.co.uk/sounds/play/w3ct4scs (around 10:00 I believe). She talks about the recent Keystone Symposium and ongoing findings. A focus seems to be microclots, viral persistence, EBV and some of Nath's findings.

Emerging Links Between COVID-19 and Cardiovascular & Cerebrovascular Thromboembolic Events: A Systematic Review Abstract COVID-19, caused by the SARS-CoV-2 virus, initially identified as a respiratory illness, has increasingly been linked to a broader range of organ complications. This...